2,4-Diaminopyrimidines as Potent Inhibitors of Trypanosoma brucei and Identification of Molecular Targets by a Chemical Proteomics Approach

• Luke Mercer,

  Affiliation SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Tana Bowling,

  Affiliation SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Joe Perales,

  Affiliation SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Jennifer Freeman,

  Affiliation SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Tien Nguyen,

  Affiliation SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Cyrus Bacchi,

  Affiliation Haskins Laboratories, Pace University, New York, New York, United States of America

  ⨯
• Nigel Yarlett,

  Affiliation Haskins Laboratories, Pace University, New York, New York, United States of America

  ⨯
• Robert Don,

  Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

  ⨯
• Robert Jacobs,

  Affiliation SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Bakela Nare

  * E-mail: bakela.nare@scynexis.com

  Affiliation SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America

  ⨯